Rockwell Medical reports Q4 adjusted EPS 4c, consensus 2c

Reports Q4 revenue $24.7M, consensus $22.1M. “In 2024, we were successful in accomplishing our objectives to achieve profitability for the full-year on an adjusted EBITDA basis, generate over $100 million in net sales, and increase our gross margin,” said Mark Strobeck, CEO. “While we expect 2025 to be a year of transition as we navigate changes within our customer base, we remain focused on sustained profitability for the full-year 2025 on an adjusted EBITDA basis. We plan to continue to identify additional business development opportunities to support our strategic objectives, diversify our product portfolio, and further optimize our business through manufacturing improvements.”